SavedAdd your journal

Journals / Endokrinolojide Diyalog Dergisi / 2010 / Cilt: 7 - Sayı: 2

Cushing’s syndrome and cardiovascular risk

Cushing sendromu ve kardiyovasküler risk

Akar Nihal BAYRAM
Reyhan ERSOY
Pages
77–80
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, cardiovascularstatusshouldbeassessedduringboththeactivephase ofthediseaseandthepost- treatmentfollow- up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cushing’ssyndrome( CS)isknowntobeassociatedwith anincreasedmortalityrateforcardiovascularevents, probablyduetotheobesity, hypertension, impairedglucosetoleranceordiabetesmellitus, hyperlipidemia, and hypercoagulability.CardiovascularcomplicationsassociatedwithCSincludecoronaryarterydisease, congestive heartfailure, andcardiacstroke.
📊
Key Findings & Data:Theremissionorcure ofCSusuallyreducesbutdoesnoteliminatethesesystemiccomplicationscompletely.
💡
Conclusion & Impact:Therefore, cardiovascularstatusshouldbeassessedduringboththeactivephase ofthediseaseandthepost- treatmentfollow- up.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cushing’ssyndrome( CS)isknowntobeassociatedwith anincreasedmortalityrateforcardiovascularevents, probablyduetotheobesity, hypertension, impairedglucosetoleranceordiabetesmellitus, hyperlipidemia, and hypercoagulability.CardiovascularcomplicationsassociatedwithCSincludecoronaryarterydisease, congestive heartfailure, andcardiacstroke. Theremissionorcure ofCSusuallyreducesbutdoesnoteliminatethesesystemiccomplicationscompletely. Therefore, cardiovascularstatusshouldbeassessedduringboththeactivephase ofthediseaseandthepost- treatmentfollow- up.

Özet

Cushingsendromunun( CS)obezite, hipertansiyon, bozulmuşglukoztoleransıveyadiabetesmellitus, hiperlipidemivehiperkoagülabilitezeminindegelişen kardiyovaskülerolaylarınnedenolduğuartmışölüm oranlarıileilişkiliolduğubilinmektedir. CSileilişkili kardiyovaskülerkomplikasyonlarkoronerarterhastalığı, konjestif kalpyetmezliğivekardiyakstrokukapsar. CS’ninremisyonuveyakürügenelliklebusistemik komplikasyonlarıazaltırancaktamamenortadankaldırmaz. Bunedenlehemhastalığınaktif döneminde hemdetedavisonrasıtakipsürecindekardiyovasküler durumdeğerlendirilmelidir.

🔖

Cite This Article

BAYRAM, A. N., ERSOY, R. (2022). Cushing’s syndrome and cardiovascular risk. Endokrinolojide Diyalog Dergisi, Cilt: 7 - Sayı: 2, 77–80. https://ajindex.com/articles/500779

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Co lao A, Pi vo nel lo N, Spi ezia S, et al. Per sis ten ce of in cre - ased car di ovas cu lar risk in pa ti ents with Cus hing’s di se ase af - ter fi ve ye ars of suc cess ful cu re. J Clin En doc ri nol Me tab 1999;84:2664-2672
  2. Fal lo F, Bu da no S, So ni no N, Mu ie san ML, Aga bi ti-Ro sei E, Bos ca ro M. Left ven tri cu lar struc tu ral cha rac te ris tics in Cus - hing’s syndro me. J Hum Hyper tens 1994;8:509-513
  3. Bos ca ro M, Bar zon L, Fal lo F, So ni no N. Cus hing’s syndro me. Lan cet 2001;357:783-791
  4. Ar nal di G, An ge li A, At kin son AB, et al. Di ag no sis and comp - li ca ti ons of of Cus hing’s syndro me: a con sen sus sta te ment. J Clin En doc ri nol Me tab 2003;88:5593-5602
  5. Wal ker BR. Glu co cor ti co ids and car di ovas cu lar di se ase. Eu - ro pe an J En doc ri nol 2007;157: 545-559
  6. Imai Y, Abe K, Sa sa ki S, et al. Al te red cir ca di an blo od pres su - re rhythm in pa ti ents with Cus hing’s syndro me. Hyper ten si on 1988;12:11-19
  7. So ni no N, Fal lo F, Opoc her G, Bos ca ro M. Hyper ten si on in Cus hing’s syndro me. Me di cal Sci en ce Re se arch 1992;20:431- 434
  8. With worth JA, Man gos GJ, Kelly JJ. Cus hing, cor ti sol, and car di ovas cu lar di se ase. Hyper ten si on 2000;36:912-916
  9. Ma gi akou MA, Smyrna ki P, Chro usos GP. Hyper ten si on in Cus hing’s syndro me. Best Pract Res Clin En doc ri nol Me tab 2006;20:467-482
  10. Fal lo F, So ni no N. Sho uld we eva lu ate for car di ovas cu lar di - se ase in pa ti ents with Cus hing’s syndro me? Clin En doc ri nol 2009;3610:1365-2265
  11. Ar nal di G, Man ci ni T, Po len ta B, Bos ca ro M. Car di ovas cu lar risk in Cus hing’s syndro me. Pi tu itary 2004;7:253-256
  12. Plotz CM, Knowl ton AI, Ra gan C. The na tu ral his tory of Cus - hing’s syndro me. Am J Med 1952;13:597-614
  13. Sof fer LJ, Ian na co ne A, Ga bu lo oe JC. Cus hing’s syndro me: a study of 50 pa ti ents. Am J Med 1961;30:129-139
  14. Su gi ha ra N, Shi mi zu M, Ki ta Y, et al. Car di ac cha rac te ris tics and pos to pe ra ti ve co ur ses in Cus hing’s syndro me. Am J Car - di ol 1992;69:1475-1480
  15. Mu ie san ML, Lu pia M, Sal vet ti M, et al. Left ven tri cu lar struc - tu ral and func ti onal cha rac te ris tics in Cus hing’s syndro me. J Am Coll Car di ol 2003;41:2275-2279
  16. Bay ram NA, Er soy R, Ay din C, et al. As sess ment of left ven - tri cu lar func ti ons by tis sue dopp ler ec ho car di og raphy in pa ti - ents with Cus hing’s di se ase. J En doc ri nol In ves